Cargando…

Clinical outcomes of breakthrough COVID-19 after booster vaccination in patients with systemic rheumatic diseases

Detalles Bibliográficos
Autores principales:	Fragoulis, George E, Karamanakos, Anastasios, Arida, Aikaterini, Bournia, Vasiliki-Kalliopi, Evangelatos, Gerasimos, Fanouriakis, Antonis, Fragiadaki, Kalliopi, Kravvariti, Evrydiki, Laskari, Katerina, Panopoulos, Stylianos, Papazoglou, Nikolaos, Pappa, Maria, Tektonidou, Maria G, Sfikakis, Petros P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Infections
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918070/ https://www.ncbi.nlm.nih.gov/pubmed/35246472 http://dx.doi.org/10.1136/rmdopen-2022-002279

Ejemplares similares

Nocebo-Prone Behaviour in Patients with Autoimmune Rheumatic Diseases during the COVID-19 Pandemic
por: Fragoulis, George E., et al.
Publicado: (2020)

Increased influenza vaccination rates in patients with autoimmune rheumatic diseases during the Covid-19 pandemic: a cross-sectional study
por: Fragoulis, George E., et al.
Publicado: (2021)

COVID-19 vaccine safety and nocebo-prone associated hesitancy in patients with systemic rheumatic diseases: a cross-sectional study
por: Fragoulis, George E., et al.
Publicado: (2021)

Introduction and switching of biologic agents are associated with antidepressant and anxiolytic medication use: data on 42 815 real-world patients with inflammatory rheumatic disease
por: Bournia, Vasiliki-Kalliopi, et al.
Publicado: (2020)

Chronological Age and DNA Damage Accumulation in Blood Mononuclear Cells: A Linear Association in Healthy Humans after 50 Years of Age
por: Vlachogiannis, Nikolaos I., et al.
Publicado: (2023)

Omicron variant dominance and anti-SARS-CoV-2 vaccination are key determinants for a milder course of COVID-19 in patients with systemic autoimmune rheumatic diseases
por: Papagoras, Charalampos, et al.
Publicado: (2023)

Normal C-reactive protein in active psoriatic arthritis: results from real-world clinical practice
por: Gialouri, Chrysoula G., et al.
Publicado: (2022)

Higher depression rates and similar cardiovascular comorbidity in psoriatic arthritis compared with rheumatoid arthritis and diabetes mellitus
por: Fragoulis, George E., et al.
Publicado: (2020)

PCSK9/LDLR System and Rheumatoid Arthritis-Related Atherosclerosis
por: Arida, Aikaterini, et al.
Publicado: (2021)

Different systemic rheumatic diseases as risk factors for COVID-19-related mortality
por: Fragoulis, George E., et al.
Publicado: (2022)

Higher frequency but similar recurrence rate of uveitis episodes in axial spondylarthritis compared to psoriatic arthritis. A multicentre retrospective study
por: Kougkas, Nikolaos, et al.
Publicado: (2023)

All-cause mortality in systemic rheumatic diseases under treatment compared with the general population, 2015–2019
por: Bournia, Vasiliki-Kalliopi, et al.
Publicado: (2021)

Late-Onset Psoriatic Arthritis: Are There Any Distinct Characteristics? A Retrospective Cohort Data Analysis
por: Gialouri, Chrysoula G., et al.
Publicado: (2023)

Different COVID-19 outcomes among systemic rheumatic diseases: a nation-wide cohort study
por: Bournia, Vasiliki-Kalliopi, et al.
Publicado: (2022)

Cardiac Catheterization versus Echocardiography for Monitoring Pulmonary Pressure: A Prospective Study in Patients with Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
por: Bournia, Vasiliki Kalliopi, et al.
Publicado: (2020)

The role of the Nocebo effect in the use of biosimilars in routine rheumatology clinical practice
por: Kravvariti, Evrydiki, et al.
Publicado: (2019)

Oxidative stress and endogenous DNA damage in blood mononuclear cells may predict anti-SARS-CoV-2 antibody titers after vaccination in older adults
por: Ntouros, Panagiotis A., et al.
Publicado: (2022)

Type I Interferon Signature in Primary Antiphospholipid Syndrome: Clinical and Laboratory Associations
por: Palli, Eleni, et al.
Publicado: (2019)

Generic and disease-adapted cardiovascular risk scores as predictors of atherosclerosis progression in SLE
por: Panopoulos, Stylianos, et al.
Publicado: (2023)

Microwave Radiometry for the Diagnosis and Monitoring of Inflammatory Arthritis
por: Laskari, Katerina, et al.
Publicado: (2023)

Adenosine-to-inosine RNA editing contributes to type I interferon responses in systemic sclerosis
por: Vlachogiannis, Nikolaos I., et al.
Publicado: (2021)

Cardiovascular Magnetic Resonance Identifies High-Risk Systemic Sclerosis Patients with Normal Echocardiograms and Provides Incremental Prognostic Value
por: Markousis-Mavrogenis, George, et al.
Publicado: (2019)

Real-Life Outcome of Lupus Nephritis with Current Therapies: Study Protocol of a Multicentre Observational Study
por: Pappa, Maria, et al.
Publicado: (2022)

Inappropriate prescribing in geriatric rural primary care: impact on adverse outcomes and relevant risk factors in a prospective observational cohort study
por: Tampaki, Maria, et al.
Publicado: (2023)

A Case of Microscopic Polyangiitis Presenting as Cranial Giant Cell Arteritis
por: Evangelatos, Gerasimos, et al.
Publicado: (2020)

The second decade of anti-TNF-a therapy in clinical practice: new lessons and future directions in the COVID-19 era
por: Evangelatos, Gerasimos, et al.
Publicado: (2022)

Choosing the Appropriate Target for the Treatment of Psoriatic Arthritis: TNFα, IL-17, IL-23 or JAK Inhibitors?
por: Gialouri, Chrysoula G., et al.
Publicado: (2022)

The diagnostic value of ultrasonography-derived edema of the temporal artery wall in giant cell arteritis: a second meta-analysis
por: Arida, Aikaterini, et al.
Publicado: (2010)

Tuberculosis and targeted synthetic or biologic DMARDs, beyond tumor necrosis factor inhibitors
por: Evangelatos, Gerasimos, et al.
Publicado: (2020)

Musculoskeletal Complications of Celiac Disease: A Case-Based Review
por: Evangelatos, Gerasimos, et al.
Publicado: (2023)

Zoledronic acid is effective in the management of migratory osteoporosis unresponsive to conservative treatment and risedronate: A case report
por: Evangelatos, Gerasimos, et al.
Publicado: (2021)

Systemic Inflammatory Response and Atherosclerosis: The Paradigm of Chronic Inflammatory Rheumatic Diseases
por: Arida, Aikaterini, et al.
Publicado: (2018)

The 5-HT1A receptor agonist buspirone improves esophageal motor function and symptoms in systemic sclerosis: a 4-week, open-label trial
por: Karamanolis, George P., et al.
Publicado: (2016)

Osteoprotegerin and MTHFR gene variations in rheumatoid arthritis: association with disease susceptibility and markers of subclinical atherosclerosis
por: Arida, Aikaterini, et al.
Publicado: (2022)

Effectiveness and Safety of Certolizumab Pegol in Axial Spondyloarthritis in a Real-World Setting in Greece: A Sub-Analysis of the Prospective Non-Interventional CIMAX Cohort Study
por: Katsifis, Gkikas, et al.
Publicado: (2022)

Lifestyle Trajectories Are Associated with Incidence of Cardiovascular Disease: Highlights from the ATTICA Epidemiological Cohort Study (2002–2022)
por: Damigou, Evangelia, et al.
Publicado: (2023)

Diet Quality and Consumption of Healthy and Unhealthy Foods Measured via the Global Diet Quality Score in Relation to Cardiometabolic Outcomes in Apparently Healthy Adults from the Mediterranean Region: The ATTICA Epidemiological Cohort Study (2002–2022)
por: Damigou, Evangelia, et al.
Publicado: (2023)

The influence of anti-cyclic citrullinated peptide on anticentromere antibody-positive rheumatoid arthritis patients: authors' response
por: Vlachoyiannopoulos, Panayiotis G, et al.
Publicado: (2010)

Systemic Lupus Erythematosus and COVID-19
por: Pappa, Maria, et al.
Publicado: (2023)

Predictors of new atherosclerotic carotid plaque development in patients with rheumatoid arthritis: a longitudinal study
por: Zampeli, Evangelia, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_j6e53psrtuhfmcv8t9bbpko1b8